FC
ALXN

Ferris Capital’s Alexion Pharmaceuticals ALXN Stock Holding History

Ferris Capital’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,931
Closed -$209K – 169
2019
Q4 		$209K Buy
+1,931
New +$207K 0.07% 153
2019
Q3 		– Sell
-1,727
Closed -$226K – 165
2019
Q2 		$226K Hold
1,727
– – 0.08% 159
2019
Q1 		$233K Sell
1,727
-29
-2% -$3.61K 0.09% 152
2018
Q4 		$171K Sell
1,756
-25
-1% -$2.96K 0.08% 158
2018
Q3 		$248K Sell
1,781
-6
-0.3% -$753 0.1% 139
2018
Q2 		$222K Sell
1,787
-33
-2% -$3.86K 0.09% 136
2018
Q1 		$203K Buy
+1,820
New +$218K 0.08% 160
2017
Q4 		– Sell
-1,640
Closed -$230K – 185
2017
Q3 		$230K Buy
1,640
+31
+2% +$4.21K 0.11% 134
2017
Q2 		$196K Buy
+1,609
New +$187K 0.09% 143

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Ferris Capital's ALXN Position: Q1 2020 in Review

Ferris Capital sold out of Alexion Pharmaceuticals (ALXN) in Q1 2020, closing a stake of 1,931 shares — an estimated $209K sold.

Ferris Capital first reported a position in ALXN in Q2 2017 and held it in 9 quarters. The position peaked at $248K in Q3 2018. 654 funds tracked by Wall St. Rank hold ALXN as of Q1 2020.

  • Ferris Capital reported no remaining Alexion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Ferris Capital sold 1,931 Alexion Pharmaceuticals shares in Q1 2020, an estimated $209K.
  • Ferris Capital first reported a position in Alexion Pharmaceuticals in Q2 2017 and held it in 9 quarters.
  • Ferris Capital's Alexion Pharmaceuticals position peaked at $248K in Q3 2018.
  • 654 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2020.

Based on Ferris Capital's 13F filing for Q1 2020, filed 13 May 2020.